Vericel (VCEL) Acquisitions (2014 - 2019)
Vericel's (VCEL) quarterly Acquisitions came in at $13.9 million in Q3 2019, down 68.75% year-on-year from $44.5 million in Q3 2018, and down 35.99% quarter-over-quarter from $21.7 million in Q2 2019.
Vericel (VCEL) Acquisitions (2014 - 2019) Analysis & Trends
Vericel has disclosed Acquisitions across 6 years of filings, most recently posting $13.9 million for Q3 2019.
- Acquisitions for Q3 2019 came in at $13.9 million, down 68.75% year-over-year; the trailing twelve-month figure through Sep 2019 was $90.8 million (up 105.36% YoY), and the FY2014 annual result was $1.4 million, changed N/A from the prior year.
- Acquisitions came in at $13.9 million for Q3 2019 at Vericel, down from $21.7 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $44.5 million in Q3 2018 to a low of -$2.3 million in Q4 2015.
- The 5-year median for Acquisitions is $353000.0 (2015), against an average of $6.1 million.
- Across the five-year window, Acquisitions tumbled 213.75% in 2017 and surged 16393.04% in 2018, its largest moves.
- Vericel's Acquisitions stood at -$2.3 million in 2015, then jumped by 43.61% to -$1.3 million in 2016, then jumped by 79.22% to -$273000.0 in 2017, then soared by 16393.04% to $44.5 million in 2018, then sank by 68.75% to $13.9 million in 2019.
- The last three Acquisitions figures came in at $13.9 million (Q3 2019), $21.7 million (Q2 2019), and $10.7 million (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 13.90 Mn |
| Jun 30, 2019 | 21.72 Mn |
| Mar 31, 2019 | 10.69 Mn |
| Sep 30, 2018 | 44.48 Mn |
| Sep 30, 2017 | -273,000.00 |
| Jun 30, 2017 | 203,000.00 |
| Mar 31, 2017 | 70,000.00 |
| Dec 31, 2016 | -1.31 Mn |
| Sep 30, 2016 | 240,000.00 |
| Jun 30, 2016 | 1.06 Mn |
| Mar 31, 2016 | 13,000.00 |
| Dec 31, 2015 | -2.33 Mn |
| Sep 30, 2015 | 775,000.00 |
| Jun 30, 2015 | 1.20 Mn |
| Mar 31, 2015 | 353,000.00 |
| Sep 30, 2014 | 2.50 Mn |
| Jun 30, 2014 | -1.05 Mn |